Figure 3.
Prognostic impact ofCASP8AP2expression in a group of 99 patients enrolled in St Jude Total Therapy Study XIII. Patients were divided into 3 equal groups according to level of CASP8AP2 expression measured by gene array at diagnosis. Event-free survival and cumulative incidence of relapse are shown.